PQMP Measure Table
| COE | Measure Name |
|---|---|
| CAPQuaM | CAPQuaM PQMP Asthma I : Rate of Emergency Department Visit Use for Children Managed for Persistent Asthma |
| CAPQuaM | CAPQuaM PQMP Asthma II: Distribution of Emergency Department Visit Use for Children Managed for Persistent Asthma |
| CAPQuaM | CAPQuaM PQMP Asthma III: Primary Care Connection Prior to Emergency Department Visits For Children with Identifiable Asthma |
| CAPQuaM | CAPQuaM PQMP Asthma IV: Primary Care Connection After Emergency Department Visits for Asthma |
| CAPQuaM | CAPQuaM PQMP Asthma V: Appropriateness of Emergency Department Visits for Children and Adolescents with Identifiable Asthma |
| CAPQuaM | CAPQuaM PQMP HROB I: High risk deliveries at facilities with 24/7 in-house physician capable of safely managing labor and delivery,and performing a cesarean section, including an emergent cesarean section |
| CAPQuaM | CAPQuaM PQMP HROB II: High risk deliveries at facilities with 24/7 in-house physician coverage dedicated to the obstetrical service by an anesthesiologist who is qualified to provide obstetrical anesthesia |
| CAPQuaM | CAPQuaM PQMP HROB III: High risk deliveries at facilities with 24/7 in-house blood banking/transfusion services available |
| CAPQuaM | CAPQuaM PQMP HROB IV: High risk deliveries at facilities with level 3 or higher NICU services on campus |
| CAPQuaM | CAPQuaM PQMP HROB V: Availability of outpatient maternal fetal medicine and specialty care for women with high risk pregnancies |
| CAPQuaM | CAPQuaM PQMP HROB VI: Availability of multidisciplinary outpatient care for women with high risk pregnancies. |
| CAPQuaM | CAPQuaM PQMP HROB VII: Assessing the availability of the preconception component of High Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy |
| CAPQuaM | CAPQuaM PQMP Medication Reconciliation for Children Measure Set I: Desirable Attributes of Medication Reconciliation by Organizational Self-report and Attestation |
| CAPQuaM | CAPQuaM PQMP Medication Reconciliation in Pediatric Mental Health Care Settings, Set I: Attributes of Medication Reconciliation by Organizational Self-report |
| CAPQuaM | CAPQuaM PQMP Mental Health Follow Up Measures 1 Timeliness of follow up visits following hospital discharge of children with a primary mental health diagnosis |
| CAPQuaM | CAPQuaM PQMP PERINATAL I: Timely temperatures for all low birthweight neonates |
| CAPQuaM | CAPQuaM PQMP PERINATAL II: Timely temperatures upon arrival in Level 2 or higher nurseries for Low BirthWeight Neonates |
| CAPQuaM | CAPQuaM PQMP PERINATAL III: Distribution of temperatures for low birthweight neonates admitted to Level 2 or higher nurseries in the first 24 hours of life |
| CAPQuaM | CAPQuaM PQMP PERINATAL IV: Thermal condition of low birth weight neonates admitted to Level 2 or higher nurseries in the first 24 hours of life |
| CEPQM | Adolescent Assessment of Preparation for Transition (ADAPT) to Adult-Focused Health Care |
| CEPQM | Children with Disabilities Algorithm (CWDA) |
| CEPQM | Consumer Assessment of Healthcare Providers and Systems Hospital Survey – Child Version (Child HCAHPS) |
| CEPQM | Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool |
| CEPQM | Pediatric All-Condition Readmission Measure |
| CEPQM | Pediatric Lower Respiratory Infection Readmission Measure |
| CHOP | Continuity of Insurance- Coverage Presumed Eligible |
| CHOP | Continuity of Insurance- Coverage Presumed Ineligible |
| CHOP | Continuity of Insurance- Duration of First Observed Enrollment |
| CHOP | Continuity of Insurance- Duration of Newborns' First Observed Enrollment |
| CHOP | Continuity of Insurance- Informed Coverage |
| CHOP | Pediatric Oral Health Pain/Inflammation Patient Reported Outcome Measure |
| CHOP | Pediatric Oral Health-Related Well-Being and Distress Patient Reported Outcome Measures |
| COE4CCN | DSD-9: Pediatric Danger to Self/Suicidality (MR): Discharge Communication to Outpatient Providers |
| COE4CCN | Family Experience with Coordination of Care (FECC) Survey |
| COE4CCN | P2: Pediatric Psychosis (MR): Screening for Drugs of Abuse in the ED |
| COE4CCN | P3: Pediatric Psychosis (MR): Timely inpatient psychiatry consultation |
| NCINQ | Adolescent Depression Monitoring |
| NCINQ | Adolescent Depression Remission/Response |
| NCINQ | Follow-up Visit for Children and Adolescents on Antipsychotics |
| NCINQ | Metabolic Monitoring for Children and Adolescents on Antipsychotics |
| NCINQ | Metabolic Screening for Children and Adolescents Newly on Antipsychotics |
| NCINQ | Sexual Activity Status Among Adolescents |
| NCINQ | Tobacco Use and Help with Quitting Among Adolescents |
| NCINQ | Use of Antipsychotics in Very Young Children |
| NCINQ | Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics |
| NCINQ | Use of Higher than Recommended Doses of Antipsychotics in Children and Adolescents |
| NCINQ | Use of Multiple Concurrent Antipsychotics in Children and Adolescents |
| PMCOE | Accurate ADHD Diagnosis |
| PMCOE | ADHD Chronic Care Follow-up |
| PMCOE | Appropriateness of Red Cell Transfusions |
| PMCOE | Behavior Therapy as First-Line Treatment for Preschool-Aged Children |
| PMCOE | Behavioral Health Risk Assessment |
| PMCOE | BMI Assessment and Recommended Weight Gain |
| PMCOE | Cesarean Delivery for Nulliparous (NTSV) Women (Appropriate Use) |
| PMCOE | Episiotomy (Overuse) |
| PMCOE | Establishment of Gestational Age |
| PMCOE | Follow-up Referral after Positive Developmental Screen |
| PMCOE | Follow-up referral tracking |
| PMCOE | Follow-up with Patient Family after Developmental Screening |
| PMCOE | Initial Baseline Screen of Nutritional Status for Every Patient Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission |
| PMCOE | Initial Risk Assessment for Immobility-related Pressure Ulcer within 24 hours of Pediatric Intensive Care Unit (PICU) Admission |
| PMCOE | Linkage between Dental Prevention and Dental Treatment Measures |
| PMCOE | Post-Partum Follow-Up and Care Coordination |
| PMCOE | Prenatal Care Screening |
| Q-METRIC | ASM5. Instruction in and demonstration of proper use of new asthma medication delivery device for children with asthma |
| Q-METRIC | AVAIL1. Reporting of CAHPS data regarding availability of specialist care for children on Medicaid |
| Q-METRIC | AVAIL2. Reporting of supplemental CAHPS data regarding availability of treatment or counseling services for children on Medicaid |
| Q-METRIC | AVAIL3. Access to Outpatient Child and Adolescent Psychiatrists, Neurodevelopmental Pediatricians, and Developmental-Behavioral Pediatricians |
| Q-METRIC | AVAIL4. Access to Outpatient Specialty Care for Children |
| Q-METRIC | AVAIL5. Access to Outpatient Dental Care |
| Q-METRIC | BMI1. Documentation of BMI percentile and weight classification for children |
| Q-METRIC | BMI2. Communication of weight classification for children who are overweight or obese |
| Q-METRIC | BMI3. Hypertension screening for children who are overweight or obese |
| Q-METRIC | BMI4. Follow-up visits for children who are obese or overweight with a weight-related comorbidity |
| Q-METRIC | BMI5. Parent report of discussion of weight concerns for child |
| Q-METRIC | IMG1. Overuse of imaging for the evaluation of children with simple febrile seizures |
| Q-METRIC | IMG2. Overuse of imaging for the evaluation of children with primary headache |
| Q-METRIC | IMG3. Overuse of imaging for the evaluation of children with post-traumatic headache |
| Q-METRIC | IMG5. Overuse of imaging: Policy for ALARA specific to imaging children |
| Q-METRIC | IMG6. Ratio of magnetic resonance imaging to computed tomography scans for the evaluation of children with atraumatic headache |
| Q-METRIC | IMG7. Ratio of magnetic resonance imaging to computed tomography scans for the evaluation of children with atraumatic seizure |
| Q-METRIC | IMG9. Overuse of computed tomography scans for the evaluation of children with first generalized afebrile, atraumatic seizure |
| Q-METRIC | SCD1. Timeliness of confirmatory testing for sickle cell disease |
| Q-METRIC | SCD10. Anticipatory guidance regarding hydroxyurea treatment for children with sickle cell disease |
| Q-METRIC | SCD12. Hemoglobin S monitoring prior to chronic transfusion among children with sickle cell disease |
| Q-METRIC | SCD13. Transcranial Doppler ultrasonography screening for children with sickle cell disease |
| Q-METRIC | SCD14. Appropriate emergency department blood testing for children with sickle cell disease |
| Q-METRIC | SCD15. Appropriate emergency department fever management for children with sickle cell disease |
| Q-METRIC | SCD16. Appropriate emergency department pain assessment for children with sickle cell disease |
| Q-METRIC | SCD17. Appropriate emergency department pain management for children with sickle cell disease |
| Q-METRIC | SCD18. Satisfaction with care from the hematologist for children with sickle cell disease |
| Q-METRIC | SCD19. Satisfaction with care in the emergency department for children with sickle cell disease |
| Q-METRIC | SCD2. Timeliness of antibiotic prophylaxis for children with sickle cell disease |
| Q-METRIC | SCD3. Appropriate antibiotic prophylaxis for children with sickle cell disease |
| Q-METRIC | SCD4. Appropriate outpatient blood testing for children with sickle cell disease |
| Q-METRIC | SCD5. Anticipatory guidance for pain management for children with sickle cell disease |
| Q-METRIC | SCD6. Anticipatory guidance for prevention and/or management of fever and severe infection in children with sickle cell disease |
| Q-METRIC | SCD7. Anticipatory guidance for prevention of stroke in children with sickle cell disease |
| Q-METRIC | SCD8. Anticipatory guidance regarding school attendance/performance for children with sickle cell disease |
| Q-METRIC | SCD9. Anticipatory guidance for prevention and management of splenic complications in children with sickle cell disease |
| Q-METRIC | SEP1. Protocol for identifying and treating children with sepsis syndrome in the emergency department |
| Q-METRIC | SEP3. Timely blood culture for children with sepsis syndrome |
| Q-METRIC | SEP4. Timely antibiotics for children with severe sepsis or septic shock |
| Q-METRIC | SEP5. Timely fluid bolus for children with severe sepsis or septic shock |
| Q-METRIC | SEP6. Documentation of heart rate during fluid resuscitation for children with severe sepsis or septic shock |
Acronyms
CAPQuAM: Collaboration for Advancing Pediatric Quality Measures
CEPQM: Center of Excellence for Pediatric Quality Measurement
CHOP: Children’s Hospital Of Philadelphia
COE4CCN: Center of Excellence on Quality of Care Measures for Children with Complex Needs
NCINQ: National Collaborative for Innovation in Quality Measurement
PMCOE: Pediatric Measurement Center of Excellence
Q-METRIC: Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium
